Hennion & Walsh Asset Management, Inc. Astrazeneca PLC Transaction History

Hennion & Walsh Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	BUY	$54.21 - $70.44 $226,868 - $294,791	4,185 New	4,185 $283,000
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $40,356 - $48,446	-681 Reduced 14.99%	3,863 $255,000
Q1 2022 Apr 26, 2022	BUY	$55.72 - $67.12 $16,381 - $19,733	294 Added 6.92%	4,544 $301,000
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $62,123 - $73,404	-1,150 Reduced 21.3%	4,250 $247,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $756,504 - $827,716	-13,616 Reduced 71.6%	5,400 $324,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $46,676 - $58,013	-964 Reduced 4.82%	19,016 $1.14 Million
Q1 2021 May 17, 2021	BUY	$47.16 - $54.44 $942,256 - $1.09 Million	19,980 New	19,980 $993,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.